William G. Glass

3.9k total citations
21 papers, 1.6k citations indexed

About

William G. Glass is a scholar working on Infectious Diseases, Immunology and Molecular Biology. According to data from OpenAlex, William G. Glass has authored 21 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Infectious Diseases, 7 papers in Immunology and 4 papers in Molecular Biology. Recurrent topics in William G. Glass's work include SARS-CoV-2 and COVID-19 Research (5 papers), HIV Research and Treatment (3 papers) and Mosquito-borne diseases and control (3 papers). William G. Glass is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (5 papers), HIV Research and Treatment (3 papers) and Mosquito-borne diseases and control (3 papers). William G. Glass collaborates with scholars based in United States, United Kingdom and Canada. William G. Glass's co-authors include Philip M. Murphy, Jean K. Lim, Thomas E. Lane, Brian R. Murphy, Kanta Subbarao, David H. McDermott, Michael T. Liu, Ji‐Liang Gao, Rushina Cholera and Alexander G. Pletnev and has published in prestigious journals such as The Journal of Experimental Medicine, The Journal of Immunology and The Journal of Physical Chemistry B.

In The Last Decade

William G. Glass

21 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
William G. Glass United States 14 639 616 365 289 238 21 1.6k
Yongjun Sui United States 20 311 0.5× 736 1.2× 75 0.2× 373 1.3× 212 0.9× 47 1.3k
J L Virelizier France 25 385 0.6× 871 1.4× 227 0.6× 208 0.7× 616 2.6× 37 2.1k
Margaret Yungbluth United States 11 701 1.1× 495 0.8× 112 0.3× 1.3k 4.4× 428 1.8× 21 1.9k
Elisabeth Aurelius Sweden 18 568 0.9× 259 0.4× 155 0.4× 371 1.3× 1.2k 4.9× 25 1.8k
Cherie Ng United States 14 369 0.6× 896 1.5× 74 0.2× 277 1.0× 307 1.3× 31 1.6k
M B Oldstone United States 26 632 1.0× 1.1k 1.9× 68 0.2× 217 0.8× 631 2.7× 35 2.1k
Marc S. Horwitz Canada 27 679 1.1× 2.0k 3.3× 86 0.2× 910 3.1× 575 2.4× 81 3.6k
Nigel J. Stevenson Ireland 21 324 0.5× 577 0.9× 91 0.2× 59 0.2× 324 1.4× 35 1.3k
C. Mee Ling Munier Australia 22 544 0.9× 758 1.2× 73 0.2× 390 1.3× 415 1.7× 42 1.8k
Yean K. Yong Malaysia 19 426 0.7× 503 0.8× 225 0.6× 156 0.5× 354 1.5× 49 1.2k

Countries citing papers authored by William G. Glass

Since Specialization
Citations

This map shows the geographic impact of William G. Glass's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William G. Glass with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William G. Glass more than expected).

Fields of papers citing papers by William G. Glass

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by William G. Glass. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William G. Glass. The network helps show where William G. Glass may publish in the future.

Co-authorship network of co-authors of William G. Glass

This figure shows the co-authorship network connecting the top 25 collaborators of William G. Glass. A scholar is included among the top collaborators of William G. Glass based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with William G. Glass. William G. Glass is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Singh, Sukrit, Vytautas Gapsys, Matteo Aldeghi, et al.. (2025). Prospective Evaluation of Structure-Based Simulations Reveal Their Ability to Predict the Impact of Kinase Mutations on Inhibitor Binding. The Journal of Physical Chemistry B. 129(11). 2882–2902. 3 indexed citations
2.
Glass, William G., et al.. (2022). Spliced isoforms of the cardiac Nav1.5 channel modify channel activation by distinct structural mechanisms. The Journal of General Physiology. 154(5). 2 indexed citations
3.
Glass, William G., Anna L. Duncan, & Philip C. Biggin. (2020). Computational Investigation of Voltage-Gated Sodium Channel β3 Subunit Dynamics. Frontiers in Molecular Biosciences. 7. 40–40. 5 indexed citations
5.
Glass, William G., Rochelle L. Argentieri, Francis X. Farrell, et al.. (2009). Generation of bleomycin-induced lung fibrosis is independent of IL-16. Cytokine. 46(1). 17–23. 4 indexed citations
6.
Gu, Rui, et al.. (2009). IL-10 is pathogenic during the development of coxsackievirus B4-induced chronic pancreatitis. Virology. 395(1). 77–86. 13 indexed citations
7.
Held, Katherine S., William G. Glass, Ted Petley, et al.. (2008). Generation of a Protective T-Cell Response Following Coronavirus Infection of the Central Nervous System Is Not Dependent on IL-12/23 Signaling. Viral Immunology. 21(2). 173–188. 16 indexed citations
8.
Liu, Changbao, et al.. (2007). IL-16 signaling specifically induces STAT6 activation through CD4. Cytokine. 38(3). 145–150. 15 indexed citations
9.
Glass, William G., Robert T. Sarisky, & Alfred M. Del Vecchio. (2006). Not-So-Sweet Sixteen: The Role of IL-16 in Infectious and Immune-Mediated Inflammatory Diseases. Journal of Interferon & Cytokine Research. 26(8). 511–520. 73 indexed citations
10.
Glass, William G., David H. McDermott, Jean K. Lim, et al.. (2006). CCR5 deficiency increases risk of symptomatic West Nile virus infection. The Journal of Experimental Medicine. 203(1). 35–40. 357 indexed citations
11.
Mbow, Moustapha, et al.. (2006). Small Molecule and Biologic Modulators of the Immune Response to Hepatitis C Virus. Mini-Reviews in Medicinal Chemistry. 6(5). 527–531. 2 indexed citations
12.
Lim, Jean K., William G. Glass, David H. McDermott, & Philip M. Murphy. (2006). CCR5: no longer a ‘good for nothing’ gene – chemokine control of West Nile virus infection. Trends in Immunology. 27(7). 308–312. 76 indexed citations
13.
Glass, William G., Jean K. Lim, Rushina Cholera, et al.. (2005). Chemokine receptor CCR5 promotes leukocyte trafficking to the brain and survival in West Nile virus infection. The Journal of Experimental Medicine. 202(8). 1087–1098. 293 indexed citations
14.
Glass, William G., Michelle J. Hickey, Jenny L. Hardison, et al.. (2004). Antibody Targeting of the CC Chemokine Ligand 5 Results in Diminished Leukocyte Infiltration into the Central Nervous System and Reduced Neurologic Disease in a Viral Model of Multiple Sclerosis. The Journal of Immunology. 172(7). 4018–4025. 109 indexed citations
15.
Glass, William G., Helene F. Rosenberg, & Philip M. Murphy. (2003). Chemokine regulation of inflammation during acute viral infection. Current Opinion in Allergy and Clinical Immunology. 3(6). 467–473. 89 indexed citations
16.
17.
Glass, William G., et al.. (2002). Mouse Hepatitis Virus Infection of the Central Nervous System: Chemokine-Mediated Regulation of Host Defense and Disease. Viral Immunology. 15(2). 261–272. 45 indexed citations
18.
Glass, William G. & Thomas E. Lane. (2002). Functional Expression of Chemokine Receptor CCR5 on CD4+T Cells during Virus-Induced Central Nervous System Disease. Journal of Virology. 77(1). 191–198. 52 indexed citations
19.
Glass, William G., Michael T. Liu, William A. Kuziel, & Thomas E. Lane. (2001). Reduced Macrophage Infiltration and Demyelination in Mice Lacking the Chemokine Receptor CCR5 Following Infection with a Neurotropic Coronavirus. Virology. 288(1). 8–17. 91 indexed citations
20.
Roehl, Holger, Judith S. Greengard, William G. Glass, et al.. (2000). Analysis of Testes and Semen from Rabbits Treated by Intravenous Injection with a Retroviral Vector Encoding the Human Factor VIII Gene: No Evidence of Germ Line Transduction. Human Gene Therapy. 11(18). 2529–2540. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026